Table 3.
Risk of gallstones in multivariate analyses of two different age groups
| Variables | Age < 50 | Age ≥ 50 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| cOR | 95% CI | adj. OR | 95% CI | p | cOR | 95% CI | adj. OR | 95% CI | p | |
| Sex | 0.90 | 0.51–1.59 | 0.92 | 0.32–2.60 | 0.87 | 1.05 | 0.75–1.47 | 0.79 | 0.49–1.27 | 0.32 |
| Bil-T | 0.74 | 0.36–1.51 | 1.08 | 0.49–2.38 | 0.85 | 1.46 | 1.01–2.11 | 1.44 | 0.95–2.16 | 0.08 |
| GOT | 0.97 | 0.94–1.01 | 0.94 | 0.87–1.02 | 0.13 | 1.02 | 1.01–1.03 | 1.01 | 0.99–1.03 | 0.38 |
| GPT | 1.00 | 0.98–1.01 | 1.02 | 0.98–1.05 | 0.31 | 1.01 | 1.00–1.02 | 1.00 | 0.99–1.02 | 0.88 |
| rGT | 1.00 | 0.98–1.01 | 1.00 | 0.98–1.02 | 0.89 | 1.00 | 1.00–1.01 | 1.00 | 1.00–1.01 | 0.28 |
| ALP | 0.99 | 0.97–1.01 | 0.99 | 0.97–1.01 | 0.45 | 1.01 | 1.00–1.01 | 1.00 | 1.00–1.01 | 0.34 |
| TC | 0.99 | 0.98–1.00 | 0.98 | 0.96–1.01 | 0.15 | 1.00 | 0.99–1.00 | 0.99 | 0.98–1.01 | 0.30 |
| LDL | 1.00 | 0.99–1.01 | 1.01 | 0.99–1.04 | 0.38 | 1.00 | 0.99–1.00 | 1.01 | 0.99–1.02 | 0.43 |
| Uric acid | 1.01 | 0.84–1.21 | 0.94 | 0.71–1.25 | 0.65 | 1.18 | 1.06–1.31 | 1.13 | 0.98–1.30 | 0.09 |
| BUN | 1.02 | 0.95–1.10 | 1.06 | 0.95–1.18 | 0.32 | 1.02 | 0.98–1.05 | 1.00 | 0.95–1.05 | 0.98 |
| Cr | 0.57 | 0.11–2.86 | 0.50 | 0.04–6.37 | 0.59 | 1.34 | 0.81–2.20 | 1.23 | 0.55–2.78 | 0.61 |
| HBV | 1.22 | 0.54–2.76 | 1.14 | 0.46–2.80 | 0.77 | 0.91 | 0.51–1.61 | 0.99 | 0.54–1.80 | 0.97 |
| HCV | – | – | 0.00 | < 0.001 | 1.00 | 2.86 | 1.68–4.88 | 2.58 | 1.43–4.68 | < 0.05 |
| Four phenotypesa | 1.50 | 1.21–1.86 | 1.73 | 1.32–2.28 | < 0.001 | 1.18 | 1.04–1.34 | 1.10 | 0.94–1.27 | 0.23 |
ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate transaminase, Bil-T total bilirubin, ALP alkaline phosphatase, AST aspartate transaminase, Bil-T total bilirubin, LDL low-density lipoprotein, TC total cholesterol, HBV hepatitis B virus, HCV hepatitis C virus; aFour phenotypes: MHNO, MHO, MANO and MAO